Report #2870832

Received Nov 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 78 yrs
State: TX
Recovered: Unknown
Vaccinated: —
Onset: Oct 21, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	G77F3	—

Symptoms (1)

Product preparation issue

Symptom narrative

received the Shingrix adjuvant only; received the Shingrix adjuvant only; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 78-year-old male patient who received Herpes zoster (Shingrix) (batch number 72R4G, expiry date 05-JUN-2027) and (batch number G77F3) for prophylaxis. On 21-OCT-2025, the patient received the 1st dose of Shingrix. On 21-OCT-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received the Shingrix adjuvant only) and inappropriate dose of vaccine administered (Verbatim: received the Shingrix adjuvant only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 21-OCT-2025 The reporter stated that the Shingrix adjuvant was not mixed with the antigen. The batch number 72R4G reported for antigen. The batch number G77F3 reported for adjuvant.